Latest Ivacaftor Stories
Global Cystic Fibrosis Market 2015-2019 is a new industry research report which profiles key players like Actavis, Novartis, Gilead Sciences, Vertex Pharmaceuticals and F Hoffmann-La Roche.
Largest pharmaceutical royalty purchase ever completed NEW YORK, Nov.
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, October 27, 2014 /PRNewswire/ -- Today, Analysts Review released its research
HAMILTON, N.J., Oct.
ChanTest’s expertise will be showcased at the North American Cystic Fibrosis Conference this month, highlighting the important research the company has conducted to help move cystic fibrosis
Expanded Collaboration Supports Phase 2 Clinical Trial Initiation of First-In-Class ENaC Inhibitor for the Treatment of Cystic Fibrosis DURHAM, N.C., Sept.
Cystic fibrosis continues to be devastating for many people around the world.
SAN FRANCISCO, Aug.
The study, led by Martina Gentzsch, PhD, provides evidence that could help drug developers improve compounds aimed at correcting CFTR proteins in cystic fibrosis patients.
CF Foundation Provided Scientific, Clinical and Significant Funding Support in Drug Development Process BETHESDA, Md., June 24, 2014 /PRNewswire-USNewswire/ -- The Cystic Fibrosis
- An imitative word; an onomatopoetic word.